FDA medical imaging appointment Mills
This article was originally published in The Gray Sheet
Executive Summary
Center for Drug Evaluation & Research's George Mills, MD, acting deputy director of the drug center's therapeutic biological oncology products division, will become director of CDER's medical imaging and radiopharmaceutical drug products division March 7. Tasked with improving CDER's knowledge and use of imaging as endpoints for clinical trials and drug approval, Mills replaces Deputy Director Sally Loewke, MD...